AP1192A - Solubilized sertraline compositions. - Google Patents

Solubilized sertraline compositions. Download PDF

Info

Publication number
AP1192A
AP1192A APAP/P/1998/001280A AP9801280A AP1192A AP 1192 A AP1192 A AP 1192A AP 9801280 A AP9801280 A AP 9801280A AP 1192 A AP1192 A AP 1192A
Authority
AP
ARIPO
Prior art keywords
composition
sertraline
matter
solubilizing agent
acid
Prior art date
Application number
APAP/P/1998/001280A
Other languages
English (en)
Other versions
AP9801280A0 (en
Inventor
Dwayne Thomas Friesen
Scott Max Herbig
Ravi Mysore Shanker
James Blair West
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971159&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AP1192(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of AP9801280A0 publication Critical patent/AP9801280A0/xx
Application granted granted Critical
Publication of AP1192A publication Critical patent/AP1192A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
APAP/P/1998/001280A 1997-07-01 1998-06-25 Solubilized sertraline compositions. AP1192A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5141397P 1997-07-01 1997-07-01

Publications (2)

Publication Number Publication Date
AP9801280A0 AP9801280A0 (en) 1998-06-30
AP1192A true AP1192A (en) 2003-07-23

Family

ID=21971159

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1998/001280A AP1192A (en) 1997-07-01 1998-06-25 Solubilized sertraline compositions.

Country Status (34)

Country Link
EP (1) EP0999829A1 (ja)
JP (1) JP2000514100A (ja)
KR (1) KR100366373B1 (ja)
CN (1) CN1261794A (ja)
AP (1) AP1192A (ja)
AR (3) AR015917A1 (ja)
AU (1) AU742535B2 (ja)
BG (1) BG103918A (ja)
BR (1) BR9810739A (ja)
CA (1) CA2290974C (ja)
CO (1) CO4940495A1 (ja)
DZ (1) DZ2548A1 (ja)
EA (1) EA002481B1 (ja)
HN (1) HN1998000102A (ja)
HR (1) HRP980377A2 (ja)
HU (1) HUP0002236A3 (ja)
ID (1) ID23429A (ja)
IL (1) IL133076A (ja)
IS (1) IS5260A (ja)
MA (1) MA24587A1 (ja)
NO (1) NO996520L (ja)
OA (1) OA11243A (ja)
PA (1) PA8454301A1 (ja)
PE (1) PE97199A1 (ja)
PL (1) PL337804A1 (ja)
SK (1) SK181099A3 (ja)
TN (1) TNSN98124A1 (ja)
TR (1) TR199903297T2 (ja)
TW (1) TW550087B (ja)
UA (1) UA67741C2 (ja)
UY (1) UY25071A1 (ja)
WO (1) WO1999001120A1 (ja)
YU (1) YU68299A (ja)
ZA (1) ZA985708B (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DZ3227A1 (fr) 1999-12-23 2001-07-05 Pfizer Prod Inc Compositions pharmaceutiques fournissant des concentrations de medicaments ameliorees
US20030086972A1 (en) * 2000-08-09 2003-05-08 Appel Leah E. Hydrogel-driven drug dosage form
AP2001002264A0 (en) 2000-08-30 2001-09-30 Pfizer Prod Inc Sustained release formulations for growth hormone secretagogues.
US20040191207A1 (en) * 2003-03-31 2004-09-30 Lipari John M. Alpha-hydroxy acid ester drug delivery compositions and methods of use
WO2008110268A1 (en) * 2007-03-12 2008-09-18 Dsm Ip Assets B.V. Cosmetic compositions
WO2011081117A1 (ja) * 2009-12-29 2011-07-07 興和株式会社 経口投与用固形医薬組成物
KR20120116422A (ko) * 2009-12-29 2012-10-22 코와 가부시키가이샤 경구 투여용 의약 조성물
CN109908354A (zh) * 2017-12-12 2019-06-21 万特制药(海南)有限公司 盐酸舍曲林口服浓缩液及其制备工艺

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0415612A2 (en) * 1989-08-30 1991-03-06 Pfizer Inc. Use of sertraline for the treatment of chemical dependencies

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4803076A (en) * 1986-09-04 1989-02-07 Pfizer Inc. Controlled release device for an active substance
ZA97976B (en) * 1996-04-05 1997-08-18 Alza Corp Uniform drug delivery theraphy.

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0415612A2 (en) * 1989-08-30 1991-03-06 Pfizer Inc. Use of sertraline for the treatment of chemical dependencies

Also Published As

Publication number Publication date
EA002481B1 (ru) 2002-06-27
UY25071A1 (es) 2000-12-29
SK181099A3 (en) 2000-07-11
AP9801280A0 (en) 1998-06-30
KR20010013365A (ko) 2001-02-26
DZ2548A1 (fr) 2003-02-08
HN1998000102A (es) 1999-01-08
MA24587A1 (fr) 1998-12-31
TR199903297T2 (xx) 2000-07-21
EP0999829A1 (en) 2000-05-17
IL133076A (en) 2003-12-10
CA2290974A1 (en) 1999-01-14
YU68299A (sh) 2002-06-19
CA2290974C (en) 2004-04-27
CN1261794A (zh) 2000-08-02
IL133076A0 (en) 2001-03-19
HUP0002236A2 (hu) 2003-08-28
EA199900962A1 (ru) 2000-08-28
WO1999001120A1 (en) 1999-01-14
IS5260A (is) 1999-11-19
AR040279A2 (es) 2005-03-23
CO4940495A1 (es) 2000-07-24
AR040280A2 (es) 2005-03-23
PA8454301A1 (es) 2000-09-29
OA11243A (en) 2003-07-24
AU7544898A (en) 1999-01-25
HRP980377A2 (en) 1999-04-30
BG103918A (en) 2000-07-31
AR015917A1 (es) 2001-05-30
HUP0002236A3 (en) 2003-12-29
NO996520D0 (no) 1999-12-28
UA67741C2 (uk) 2004-07-15
PE97199A1 (es) 1999-10-05
PL337804A1 (en) 2000-09-11
JP2000514100A (ja) 2000-10-24
KR100366373B1 (ko) 2003-01-14
ID23429A (id) 2000-04-20
AU742535B2 (en) 2002-01-03
TNSN98124A1 (fr) 2005-03-15
BR9810739A (pt) 2000-09-12
TW550087B (en) 2003-09-01
NO996520L (no) 2000-02-29
ZA985708B (en) 2000-01-10

Similar Documents

Publication Publication Date Title
JP3382950B2 (ja) 医薬品用の徐放性マトリックス
EA004443B1 (ru) Лекарственная форма для контролируемого высвобождения ципрофлоксацина для приема один раз в день
JP2002080398A (ja) ｐＨに依存する多相的な放出を伴う経口用の固体の薬学的組成物
RU2237480C2 (ru) Непосредственно прессуемая матрица для регулируемого высвобождения однократных ежедневных доз кларитромицина
ES2852899T3 (es) Formulaciones estabilizadas de molindona
AP1199A (en) Delayed-release dosage forms of sertraline.
AP1192A (en) Solubilized sertraline compositions.
US7063864B1 (en) Morphine sulphate microgranules, method for preparing same and compositions containing same
ES2321908T3 (es) Preparaciones farmaceuticas de liberacion prolongada independientemente del ph.
JP2646170B2 (ja) 徐放性塩酸オキシブチニン製剤
DE60319983T2 (de) Universelle Zusammensetzung zur kontrollierten Wirkstoffabgabe enthaltend Chitosan
JP5105684B2 (ja) 持続性医薬製剤
JPH0748256A (ja) ニセルゴリンを含有する制御放出性の製薬組成物
KR20230067636A (ko) 듀테트라베나진을 포함하는 다중미립자 제형
US20040208926A1 (en) Solubilized sertraline compositions
NZ501250A (en) Solubilized sertraline compositions
KR20010078703A (ko) 신규 제약 제제
CZ464199A3 (cs) Solubilizované sertralinové kompozice
MXPA99012101A (en) Solubilized sertraline compositions
BR102018016507A2 (pt) Composição líquida de liberação prolongada de guaifenesina
JPWO2016117642A1 (ja) フィルム製剤
KR20040044197A (ko) 약학 제제
MXPA99012082A (en) Delayed-release dosage forms of sertraline